Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
The sales slump endured by the medical industry as the economic crisis hit may be over, according to Johnson & Johnson CEO William Weldon.
Johnson & Johnson’s (NYSE:JNJ) latest earnings statement reveals deep holes in profits due to costs associated with product liability charges and legal settlements in 4th quarter and full year of 2011.
The FDA’s Center for Devices & Radiological Health announces its strategic priorities for 2012, including final versions of all guidance documents, guidelines for acceptable clinical data from foreign countries, streamlining the recall process and creating a framework for post-market surveillance.